Comparison of Time to Treatment Between Intravenous and Endovascular Thrombolytic Treatments for Acute Ischemic Stroke

BACKGROUND: Intravenous (IV) recombinant tissue plasminogen activator (rt-PA) is used to treat acute ischemic stroke (AIS) within 4.5 hours of symptom onset. Endovascular treatment (ET) may provide higher rates of recanalization, but longer time to treatment may limit comparative clinical benefit an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Asaithambi, Ganesh, Hassan, Ameer E., Chaudhry, Saqib A., Rodriguez, Gustavo J., Suri, M. Fareed K., Taylor, Robert A., Ezzeddine, Mustapha A., Qureshi, Adnan I.
Formato: Artigo
Lenguaje:Inglês
Publicado: Zeenat Qureshi Stroke Research Center 2011
Materias:
Original Contribution
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3317284/
https://ncbi.nlm.nih.gov/pubmed/22518266
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares